These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1230 related items for PubMed ID: 8614504

  • 21. Cognitive phenotypes in Alzheimer's disease and genetic risk.
    Snowden JS, Stopford CL, Julien CL, Thompson JC, Davidson Y, Gibbons L, Pritchard A, Lendon CL, Richardson AM, Varma A, Neary D, Mann D.
    Cortex; 2007 Oct; 43(7):835-45. PubMed ID: 17941342
    [Abstract] [Full Text] [Related]

  • 22. Apolipoprotein E type epsilon4 allele, heritability and age at onset in twins with Alzheimer disease and vascular dementia.
    Bergem AL, Lannfelt L.
    Clin Genet; 1997 Nov; 52(5):408-13. PubMed ID: 9520135
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cognitive deficits and polymorphism of apolipoprotein E in Alzheimer's disease.
    Luczywek E, Nowicka A, Pfeffer A, Czyzewski K, Styczyńska M, Lałowski M, Barcikowska M.
    Dement Geriatr Cogn Disord; 2002 Mar; 13(3):171-7. PubMed ID: 11893839
    [Abstract] [Full Text] [Related]

  • 28. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD, Fisk JD, Rockwood K.
    Dement Geriatr Cogn Disord; 2003 Mar; 15(1):1-5. PubMed ID: 12457072
    [Abstract] [Full Text] [Related]

  • 29. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence.
    Jelic V, Julin P, Shigeta M, Nordberg A, Lannfelt L, Winblad B, Wahlund LO.
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):59-65. PubMed ID: 9221969
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Preclinical memory profile in Alzheimer patients with and without allele APOE-epsilon4.
    Estévez-González A, García-Sánchez C, Boltes A, Otermín P, Baiget M, Escartín A, del Rio E, Gironell A, Kulisevsky J.
    Eur Neurol; 2004 Jul; 51(4):199-205. PubMed ID: 15159600
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.
    Dement Geriatr Cogn Disord; 2006 Jul; 22(1):73-82. PubMed ID: 16699282
    [Abstract] [Full Text] [Related]

  • 34. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.
    Biol Psychiatry; 2004 Nov 01; 56(9):670-6. PubMed ID: 15522251
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Missing apolipoprotein E ε4 allele associated with nonamnestic Alzheimer's disease in a Tunisian population.
    Fray S, Achouri-Rassas A, Belal S, Messaoud T.
    J Genet; 2022 Nov 01; 101():. PubMed ID: 36226340
    [Abstract] [Full Text] [Related]

  • 37. Spectral analysis of EEG in Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M, Partanen J, Könönen M, Soininen H, Helisalmi S, Mannermaa A, Ryynänen M, Hartikainen P, Riekkinen P.
    Neurobiol Aging; 1996 Nov 01; 17(4):523-6. PubMed ID: 8832625
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
    Suh GH, Jung HY, Lee CU, Oh BH, Lee SK, Lee N, Kim J, Kee BS, Ko D, Kim YH, Ju YS, Hong I, Choi S, Korean Galantamine Study Group.
    Dement Geriatr Cogn Disord; 2006 Nov 01; 21(1):33-9. PubMed ID: 16254428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.